Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
224.5 SEK | +2.05% | +1.35% | +5.90% |
Feb. 07 | Transcript : CellaVision AB, Q4 2023 Earnings Call, Feb 07, 2024 | |
Feb. 07 | CellaVision AB Proposes Dividend for the Year 2023 | CI |
Sales 2024 * | 779M 71.4M | Sales 2025 * | 889M 81.44M | Capitalization | 5.35B 490M |
---|---|---|---|---|---|
Net income 2024 * | 174M 15.94M | Net income 2025 * | 218M 19.97M | EV / Sales 2024 * | 6.72 x |
Net cash position 2024 * | 117M 10.72M | Net cash position 2025 * | 208M 19.07M | EV / Sales 2025 * | 5.79 x |
P/E ratio 2024 * |
30.9
x | P/E ratio 2025 * |
24.5
x | Employees | - |
Yield 2024 * |
1.1% | Yield 2025 * |
1.23% | Free-Float | 61.96% |
Latest transcript on CellaVision AB
1 day | +2.05% | ||
1 week | +1.35% | ||
Current month | -6.07% | ||
1 month | -3.02% | ||
3 months | +12.47% | ||
6 months | +82.82% | ||
Current year | +5.90% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 224.5 | +2.05% | 6,409 |
24-04-18 | 220 | +0.69% | 4,457 |
24-04-17 | 218.5 | -1.35% | 7,224 |
24-04-16 | 221.5 | +2.07% | 9,793 |
24-04-15 | 217 | -2.03% | 7,887 |
Delayed Quote Nasdaq Stockholm, April 19, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.90% | 480M | |
-46.92% | 2.56B | |
+7.27% | 1.66B | |
-15.17% | 1.45B | |
+18.55% | 1.2B | |
-15.69% | 978M | |
-24.43% | 875M | |
-9.20% | 698M | |
-17.12% | 687M | |
-.--% | 301M |
- Stock Market
- Equities
- CEVI Stock